Total Payments
$25,394
2024 Payments
$5,347
Companies
27
Transactions
194
Medicare Patients
3,003
Medicare Billing
$691,255
Payment Breakdown by Category
Other$7,900 (31.1%)
Consulting$6,800 (26.8%)
Food & Beverage$6,324 (24.9%)
Travel$3,695 (14.6%)
Education$674.61 (2.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7,900 | 3 | 31.1% |
| Consulting Fee | $6,800 | 3 | 26.8% |
| Food and Beverage | $6,324 | 159 | 24.9% |
| Travel and Lodging | $3,695 | 19 | 14.6% |
| Education | $674.61 | 10 | 2.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Fresenius USA Marketing, Inc. | $14,681 | 55 | $0 (2023) |
| SCPHARMACEUTICALS INC. | $4,758 | 9 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $3,248 | 31 | $0 (2024) |
| NxStage Medical, Inc. | $541.79 | 12 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $443.03 | 19 | $0 (2024) |
| AKEBIA THERAPEUTICS INC | $250.80 | 11 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $224.61 | 5 | $0 (2019) |
| Relypsa, Inc. | $182.21 | 8 | $0 (2019) |
| Outset Medical Inc | $124.20 | 1 | $0 (2023) |
| Ardelyx, Inc. | $100.27 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,347 | 36 | SCPHARMACEUTICALS INC. ($4,758) |
| 2023 | $413.92 | 12 | Outset Medical Inc ($124.20) |
| 2022 | $4,433 | 22 | Fresenius USA Marketing, Inc. ($4,159) |
| 2021 | $371.12 | 11 | AstraZeneca Pharmaceuticals LP ($166.68) |
| 2020 | $58.62 | 3 | Otsuka America Pharmaceutical, Inc. ($43.98) |
| 2019 | $594.63 | 23 | NxStage Medical, Inc. ($216.84) |
| 2018 | $3,297 | 30 | Otsuka America Pharmaceutical, Inc. ($2,974) |
| 2017 | $10,878 | 57 | Fresenius USA Marketing, Inc. ($10,284) |
All Payment Transactions
194 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $45.97 | General |
| Category: Cardiology | ||||||
| 12/04/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Consulting Fee | Cash or cash equivalent | $1,650.00 | General |
| Category: Cardiology | ||||||
| 12/04/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $23.80 | General |
| 11/20/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: NEPHROLOGY | ||||||
| 11/20/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Cardiology | ||||||
| 11/14/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $30.24 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Consulting Fee | Cash or cash equivalent | $2,750.00 | General |
| Category: Cardiology | ||||||
| 11/11/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $139.59 | General |
| Category: Cardiology | ||||||
| 11/07/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $28.71 | General |
| Category: Inflammation | ||||||
| 11/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Cardio-renal | ||||||
| 10/09/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Food and Beverage | In-kind items and services | $27.32 | General |
| Category: Nephrology | ||||||
| 09/04/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $28.70 | General |
| Category: Inflammation | ||||||
| 08/27/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/23/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Education | In-kind items and services | $24.61 | General |
| Category: Nephrology | ||||||
| 07/17/2024 | AKEBIA THERAPEUTICS INC | Auryxia (Drug), Vafseo | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: Nephrology | ||||||
| 07/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/01/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $28.55 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/26/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/05/2024 | Amgen Inc. | PROCYSBI (Biological) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/03/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/21/2024 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $27.03 | General |
| Category: Nephrology | ||||||
| 05/16/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/15/2024 | AKEBIA THERAPEUTICS INC | Auryxia (Drug), Vafseo | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: Nephrology | ||||||
| 05/14/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $2.38 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 703 | 1,280 | $327,666 | $149,370 |
| 2022 | 9 | 687 | 1,345 | $298,850 | $150,436 |
| 2021 | 10 | 736 | 1,541 | $352,599 | $181,868 |
| 2020 | 10 | 877 | 2,238 | $474,985 | $209,581 |
Total Patients
3,003
Total Services
6,404
Medicare Billing
$691,255
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90966 | Home dialysis services per month (20 years or older) | Office | 2023 | 39 | 295 | $163,125 | $65,379 | 40.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 161 | 268 | $44,220 | $25,353 | 57.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 170 | 340 | $37,400 | $21,106 | 56.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 86 | 88 | $27,720 | $11,887 | 42.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 68 | 100 | $18,500 | $9,387 | 50.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 43 | 44 | $9,460 | $4,341 | 45.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 62 | 66 | $9,570 | $3,649 | 38.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 16 | 18 | $4,410 | $2,570 | 58.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 11 | 14 | $6,160 | $2,369 | 38.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $4,731 | $2,077 | 43.9% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 13 | 13 | $2,145 | $1,218 | 56.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 15 | 15 | $225.00 | $33.00 | 14.7% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2022 | 42 | 322 | $144,900 | $73,308 | 50.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 232 | 487 | $53,570 | $27,689 | 51.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 107 | 200 | $33,000 | $16,304 | 49.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 85 | 85 | $26,775 | $13,379 | 50.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 59 | 61 | $13,115 | $6,602 | 50.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 69 | 82 | $9,430 | $4,950 | 52.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 34 | 41 | $7,585 | $3,717 | 49.0% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 32 | 38 | $6,270 | $2,930 | 46.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 27 | 29 | $4,205 | $1,558 | 37.0% |
| 90966 | Home dialysis services per month, patient 20 years of age or older | Office | 2021 | 58 | 429 | $193,050 | $99,400 | 51.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 236 | 573 | $63,030 | $33,066 | 52.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 78 | 128 | $21,120 | $10,638 | 50.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 87 | 93 | $19,995 | $10,125 | 50.6% |
About Dr. Usama Hussein, MD
Dr. Usama Hussein, MD is a Nephrology healthcare provider based in Virginia Beach, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/27/2007. The National Provider Identifier (NPI) number assigned to this provider is 1194907527.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Usama Hussein, MD has received a total of $25,394 in payments from pharmaceutical and medical device companies, with $5,347 received in 2024. These payments were reported across 194 transactions from 27 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($7,900).
As a Medicare-enrolled provider, Hussein has provided services to 3,003 Medicare beneficiaries, totaling 6,404 services with total Medicare billing of $691,255. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Virginia Beach, VA
- Active Since 11/27/2007
- Last Updated 10/16/2012
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1194907527
Products in Payments
- Not Product Related (Medical Supply) $9,919
- FUROSCIX (Drug) $4,758
- JYNARQUE (Drug) $3,180
- Velphoro (Drug) $405.40
- FARXIGA (Drug) $233.70
- 2008K @ Home (Device) $226.10
- Auryxia (Drug) $224.62
- ACTHAR (Biological) $224.61
- Veltassa (Drug) $182.21
- LOKELMA (Drug) $179.52
- SAMSCA (Drug) $162.60
- NXSTAGE SYSTEM ONE (Device) $136.48
- IBSRELA (Drug) $100.27
- LIBERTY SELECT CYCLER (Device) $94.99
- Rituxan (Biological) $93.92
- System One (Device) $93.48
- SYSTEM ONE (Device) $60.72
- TAVNEOS (Drug) $57.41
- TARPEYO (Drug) $56.24
- Uloric (Drug) $55.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.